Acessibilidade / Reportar erro

Trypanosoma cruzi seroprevalence and associated risk factors in cancer patients from Southern Brazil

Abstract:

INTRODUCTION:

The aim of this study was to investigate the prevalence of Chagas disease in patients treated at a Public Oncology Service in the City of Pelotas, Southern Brazil.

METHODS:

This study included 200 individuals undergoing cancer treatment and involved the use of a questionnaire and venous blood collection for the detection of anti-Trypanosoma cruzi antibody.

RESULTS:

The study found a 5% prevalence of patient seropositivity. Significant variables are presented and discussed in the article.

CONCLUSIONS:

Serological T. cruzi checks are recommended in cancer patients, especially individuals from endemic areas in Brazil and other Latin American countries.

Keywords:
Cancer; Chagas disease; Trypanosoma cruzi

Sociedade Brasileira de Medicina Tropical - SBMT Sociedade Brasileira de Medicina Tropical - SBMT, Núcleo de Medicina Tropical – UnB, Sala 43C – 70904-970, E-mails: rsbmt@uftm.edu.br | artes.rsbmt@gmail.com | sbmt@sbmt.org.br , WhatsApp: SBMT (61) 9.9192-6496, WhatsApp: RSBMT (34) 9.9996-5807 - Brasília - DF - Brazil
E-mail: rsbmt@uftm.edu.br